DTCP-Hib vaccine (Tianjin CanSino Biotechnology)

N/A

Report date: 2023/08/17 20:03:08

Base Information

Drug NameDTCP-Hib vaccine (Tianjin CanSino Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanusDiphtheriaHaemophilus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTianjin Cansino Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesCanSino Biologics IncTianjin Cansino Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsTetanusDiphtheriaHaemophilus Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A